Monograph

A16AX03 - Sodium Phenylbutyrate

Propably not porphyrinogenic

PNP

Rationale

Sodium phenylbutyrate does not affect the activity of cytochrome P450 enzymes.

Metabolism and pharmacokinetics

Similar drugs

Explore alternative drugs in similar therapeutic classes A16A / A16AX or go back.

Tradenames and packages

From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.

Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.

Netherlands

Ammonaps · Ammonaps 500 mg tabletten · Ammonaps 940 mg/g granulaat · PHEBURANE · PHEBURANE 350 mg/ml orale oplossing · Pheburane 483 mg/g, granulaat

Belgium

Ammonaps · Ammonaps 500 mg comp. · Ammonaps 940 mg/g gran. · Pheburane · Pheburane 350 mg/ml sol. buv. · Pheburane 483 mg/g gran.

United Kingdom

Ammonaps · Ammonaps 500mg tablets · Ammonaps 940mg/g granules · Pheburane · Pheburane 483mg/g granules · Sodium phenylbutyrate · Sodium phenylbutyrate 1.25g/5ml oral solution · Sodium phenylbutyrate 1.25g/5ml oral suspension · Sodium phenylbutyrate 1.83g/5ml oral solution · Sodium phenylbutyrate 1g/5ml oral solution · Sodium phenylbutyrate 1g/5ml oral suspension · Sodium phenylbutyrate 250mg/5ml oral solution · Sodium phenylbutyrate 500mg capsules · Sodium phenylbutyrate 5mg capsules · Sodium phenylbutyrate 625mg/5ml oral solution · Sodium phenylbutyrate 625mg/5ml oral suspension · Sodium phenylbutyrate 650mg/5ml oral solution · Sodium phenylbutyrate 650mg/5ml oral suspension · Sodium phenylbutyrate 916.7mg/5ml oral solution

Denmark